{"transactions":[{"id":731558,"issuer":{"id":1860,"kind":"organization","name":"Liquidia Corp","symbol":"LQDA"},"owners":[{"id":36670,"kind":"person","name":"deGoa Damian","position":1,"cik":"0001836165","reported_name":"deGoa Damian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-18T20:35:14.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":5882,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"The RSUs shall vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the day prior to the Issuer's next annual shareholder meeting following the date of grant."}],"balance_after":92353,"source":{"system":"sec-edgar","filing":"0001104659-26-075788","document":"tm2618309-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819576/000110465926075788/tm2618309-4_4seq1.xml","form_type":"4"}},{"id":1104528,"issuer":{"id":1860,"kind":"organization","name":"Liquidia Corp","symbol":"LQDA"},"owners":[{"id":36670,"kind":"person","name":"deGoa Damian","position":1,"cik":"0001836165","reported_name":"deGoa Damian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-20T20:30:45.000Z","date":"2025-06-17","kind":"grant","planned":false,"acquired":true,"shares":18396,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"The RSUs shall vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the day prior to the Issuer's next annual shareholder meeting following the date of grant."}],"balance_after":86471,"source":{"system":"sec-edgar","filing":"0001104659-25-061186","document":"tm2518541-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819576/000110465925061186/tm2518541-2_4seq1.xml","form_type":"4"}},{"id":1470260,"issuer":{"id":1860,"kind":"organization","name":"Liquidia Corp","symbol":"LQDA"},"owners":[{"id":36670,"kind":"person","name":"deGoa Damian","position":1,"cik":"0001836165","reported_name":"deGoa Damian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-25T01:36:25.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":20359,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"The RSUs shall vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the day prior to the Issuer's next annual shareholder meeting following the date of grant."}],"balance_after":68075,"source":{"system":"sec-edgar","filing":"0001104659-24-074469","document":"tm2418154-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819576/000110465924074469/tm2418154-2_4seq1.xml","form_type":"4"}},{"id":1847398,"issuer":{"id":1860,"kind":"organization","name":"Liquidia Corp","symbol":"LQDA"},"owners":[{"id":36670,"kind":"person","name":"deGoa Damian","position":1,"cik":"0001836165","reported_name":"deGoa Damian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-21T21:03:35.000Z","date":"2023-06-19","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 36 equal monthly installments and will become fully vested on June 19, 2026."}],"balance_after":20000,"derivative":{"exercise_price":8.63,"exercise_date":"2026-06-19","expiration_date":"2033-06-19","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-23-073397","document":"tm2317720-11_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819576/000110465923073397/tm2317720-11_4seq1.xml","form_type":"4"}},{"id":2223679,"issuer":{"id":1860,"kind":"organization","name":"Liquidia Corp","symbol":"LQDA"},"owners":[{"id":36670,"kind":"person","name":"deGoa Damian","position":1,"cik":"0001836165","reported_name":"deGoa Damian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-22T20:30:33.000Z","date":"2022-06-17","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 36 equal monthly installments and will become fully vested on June 17, 2025."}],"balance_after":20000,"derivative":{"exercise_price":4.86,"exercise_date":"2025-06-17","expiration_date":"2032-06-17","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-22-073525","document":"tm2219055-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819576/000110465922073525/tm2219055-1_4seq1.xml","form_type":"4"}},{"id":2293358,"issuer":{"id":1860,"kind":"organization","name":"Liquidia Corp","symbol":"LQDA"},"owners":[{"id":36670,"kind":"person","name":"deGoa Damian","position":1,"cik":"0001836165","reported_name":"deGoa Damian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-20T20:36:01.000Z","date":"2022-03-31","kind":"grant","acquired":true,"shares":4625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"On March 31, 2022, 4,625 shares of the Issuer's common stock which were previously subject to a holdback pursuant to the terms of the merger agreement for Issuer's acquisition of RareGen, LLC (\"RareGen\") were released to the Reporting Person. The merger agreement provided that certain shares of the Issuer's common stock issuable to members of RareGen at the closing of the transaction would be held back as partial security for the benefit of the Issuer with respect to any indemnifiable damages pursuant to the indemnification obligations of the members of RareGen. The shares would subsequently be released for no additional consideration, subject to the cancellation of shares of the Issuer's common stock in connection with any such indemnifiable damages."}],"balance_after":47716,"source":{"system":"sec-edgar","filing":"0001104659-22-047870","document":"tm2213052-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819576/000110465922047870/tm2213052-3_4seq1.xml","form_type":"4"}},{"id":2625609,"issuer":{"id":1860,"kind":"organization","name":"Liquidia Corp","symbol":"LQDA"},"owners":[{"id":36670,"kind":"person","name":"deGoa Damian","position":1,"cik":"0001836165","reported_name":"deGoa Damian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-23T22:11:07.000Z","date":"2021-07-21","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests over a four-year period with 25% of the shares of common stock underlying the option vesting on the one-year anniversary of the grant date and the remaining 75% of the shares of common stock underlying the option vesting in equal monthly installments thereafter, becoming fully vested on July 21, 2025; provided, however, that notwithstanding the foregoing vesting schedule, 50% of the shares of common sock underlying the option will vest upon U.S. Food and Drug Administration (FDA) tentative approval of the Issuer's New Drug Application for LIQ861."}],"balance_after":10000,"derivative":{"exercise_price":2.54,"expiration_date":"2031-07-21","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-21-095507","document":"tm2123135-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819576/000110465921095507/tm2123135-2_4seq1.xml","form_type":"4"}},{"id":2943904,"issuer":{"id":1860,"kind":"organization","name":"Liquidia Corp","symbol":"LQDA"},"owners":[{"id":36670,"kind":"person","name":"deGoa Damian","position":1,"cik":"0001836165","reported_name":"deGoa Damian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2020-12-16T02:12:34.000Z","date":"2020-12-14","kind":"grant","acquired":true,"shares":2000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests over a four-year period with 25% of the shares of common stock underlying the option vesting on the one-year anniversary of the grant date and the remaining 75% of the shares of common stock underlying the option vesting in equal monthly installments thereafter, becoming fully vested on December 14, 2024; provided, however, that, notwithstanding the foregoing vesting schedule, (x) 25% of the shares of common stock underlying the option will vest upon U.S. Food and Drug Administration tentative approval of the issuer's New Drug Application for LIQ861 prior to June 30, 2022 and"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"(y) 25% of the shares of common stock underlying the option will vest upon commercial availability of subcutaneous treprostinil with cartridge supplies sufficient to support the market for one year prior to December 31, 2021; provided, further, that upon a Change in Control (as defined in the accompanying Nonstatutory Stock Option Agreement) 100% of the unvested portion of the option shall become vested and exercisable as of the date of the Change in Control, provided that Mr. deGoa is actively employed with Liquidia Technologies, Inc. on such date."}],"balance_after":2000000,"derivative":{"exercise_price":3,"expiration_date":"2030-12-14","underlying":"Common Stock","underlying_shares":2000000},"source":{"system":"sec-edgar","filing":"0001104659-20-135897","document":"tm2037368-4_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819576/000110465920135897/tm2037368-4_4.xml","form_type":"4"}}]}